baber/WOPTO huggingface dataset:
Patent EP-0594865-A4 (EP)
Title: Thin-strip cast piece of austenitic stainless steel, thin-strip cold-rolled steel plate and method of manufacturing the same
Inventor: SUEHIRO TOSHIYUKI NIPPON STEEL
IPC: B22D11/06
Filed: 1993-04-16
Abstract: This invention relates to a cast piece of austenitic stainless steel produced on a double-roll continuous casting machine, a cold-rolled steel plate, and a method of manufacturing them, and aims at providing a thin austenitic stainless steel plate free from the occurrence of surface roughening during cold molding operation. A thin-strip cast piece is produced by a double roll continuous casting method with the degree of segregation of Ni, which is defined by the following equation (1), at the portion of the cast piece which is in the vicinity of the center of a cross section thereof regulated to not lower than 0.9, and the components of the cast piece are regulated so that  delta -Fecal. (%) defined by the following equation (2) is not less than 6, the resultant cast piece being subjected to cold rolling once or twice to obtain a steel plate. According to this method, the casting is done with a drum pressing force per unit length of 3-25 Kg/mm applied in the widthwise direction of the cooling drum on a kissing point. Degree of segregation of Ni = Average quantity (%) of Ni a segregated portion/Average quantity (%) of Ni in a cast piece ... (1)  delta Fecal. (%) = 3(Cr + 1.5Si + Mo + 0.5Nb) - 2.8(Ni + 0.5Cu + 0.5Mn + 30C + 30N) - 19.8 (wherein the quantity of components is expressed by mass %)... (2).
Patent EP-0644937-A4 (EP)
Title: Therapeutic and diagnostic methods based on neurotrophin-4 expression.
IPC: A61K38/22
Filed: 1993-06-11
Abstract: The present invention relates to neurotrophin-4 (NT-4), a newly characterized member of the BDNF/NGF/NT-3 gene family. The present invention provides for nucleic acid molecules encoding NT-4. Such molecules may comprise a sequence substantially as set forth for NT-4 in the figure [SEQ ID NO:1 (NT-4, viper)]. The present invention provides for therapeutic and diagnostic methods based on human NT-4 expression, specifically the potential to treat motor neuron diseases and prostate localized diseases, immunological related neuromuscular disorders, and peripheral and central nervous system disorders including Alzheimer's disease, Parkinson's disease and Huntington's chorea and epilepsy.
Patent EP-0680733-A4 (EP)
Inventor: INOUE KANJI
IPC: A61F2/06
Filed: 1993-08-20
Abstract: Le procédé consiste à cintrer un vaisseau sanguin artificiel A. Le vaisseau sanguin artificiel A est constitué d'une paire d'éléments annulaires en fil (101 - 102) éloignés l'un de l'autre et d'un élément tubulaire extérieur (7) reliant les éléments annulaires en fil (101 - 102). Cet élément tubulaire est réalisé au moyen d'une feuille flexible tendue. Outre les éléments annulaires en fil (101 - 102), l'élément tubulaire (7) comporte des éléments annulaires intermédiaires en fil (12). Ceux-ci sont disposés de façon régulière et solidement cousus ou fixés à l'élément tubulaire (7) au niveau de leurs parties circonférentielles. La traction vers l'avant de l'élément annulaire postérieur en fil (101) vers les points de segmentation (411 - 431) diamétralement opposées (7) fait avancer au niveau des points intermédiaires (421 - 441) les segments de l'élément annulaire postérieur en fil (101) lequel est bloqué entres les points de segmentations (411 - 431) par des proéminences (18c) ménagées sur la surface conique (18d) d'un cylindre (18) en forme d'entonnoir. Cela fait que l'élément annulaire postérieur en fil (101) peut être ondulé. Les segments situés au niveau des points de segmentation (411 - 431) dépasssent vers l'avant, formant ainsi des crêtes, les segments des points intermédiaires (421 - 441) formant des creux. En continuant la traction vers l'avant au niveau des points de segmentation (411 - 431), les éléments annulaires intermédiaires en fil (12) ainsi que l'élément annulaire antérieur en fil (102) peuvent être ondulés de la même manière que l'élément (101), grâce à l'effet de butée de la surface conique (18d) et des proéminences (18). Ce dispositif permet de cintrer le vaisseau sanguin artificiel sur toute sa longueur en petits segments.
Patent EP-0682504-A4 (EP)
Title: Inflatable body support.
Inventor: SPAHN JAMES G
IPC: A61G7/05
Filed: 1993-09-30
Abstract: In combination with an inflatable body support formed from a pair of plastic sheets joined together forming an air pressurizable chamber therebetween, the sheets having a plurality of aligned holes extending therethrough with the sheets being joined together around the circumference of each hole allowing body heat and moisture to flow through each hole but preventing air flow from the chamber into each hole, thereby providing an air cushion for supporting a person positioned thereatop that dissipates pressure, heat and moisture to prevent the onset of pressure sores and ulcers, the improvement which comprises: occluding the holes over which the torso, head and limbs of a person positioned atop the inflatable body support would not lie, thereby reducing the distension of the inflatable body support surrounding the occluded holes thereby volume centering the air within the air pressurizable chamber under a person positioned atop the inflatable body support; providing a pair of micro and macro adjustable, separable, and generally U-shaped anchoring straps, each strap having two generally boomerang-shaped halves disposed in mirror image relationship; and a novel connector that may be opened by two fingers that removably attaches the anchoring straps to the inflatable body support.
Patent EP-0696502-A4 (EP)
Inventor: HIRATA JUN
IPC: C08J7/04
Filed: 1994-08-03
Abstract: Feuille polyester facile à coller présentant des propriétés antistatiques, une capacité de glissement, un pouvoir adhésif et antiblocage, une résistance à l'écaillage excellents. Ladite feuille peut être utilisée sous forme de support d'enregistrement magnétique, de divers matériaux photographiques, de matériaux d'emballage, de matériau d'isolation électrique et de matériaux industriels d'usage général. Cette feuille se compose d'une base polyester sur au moins une surface de laquelle un mélange constitué d'une composition polyester et une cire oxydée et/ou une cire naturelle est formé, ladite composition comportant un glycol de polyoxyalkylène à raison de 1 % ou plus à moins de 40 % en poids.
Patent EP-0737300-A4 (EP)
Title: Laser printer power saver
Inventor: DORNIER PASCAL
IPC: G06F1/32
Filed: 1994-12-28
Abstract: A system using a printer (13) with a fuser-heater (15) has control member (22) for turning off the fuser-heater (15) during times when no printing is required, while leaving the rest of the printing system operable. Time between print requests (twi) is monitored, and the fuser-heater (15) is turned off when a preset time (Ttrig) is reached without a print request. A next request turns the fuser-heater (15) back on again. Data is accepted at a reduced rate while a heater warms up.
Patent EP-0717045-A4 (EP)
Title: Process for producing indolocarbazole derivative
Inventor: KINUGAWA MASAHIKO
IPC: C07D498/22
Filed: 1995-06-30
Abstract: A process for producing an indolocarbazole derivative represented by general formula (II) by the acidic treatment of a silylated indolocarbazole derivative represented by general formula (VI) wherein R<1>, R<2> and R<3> represent each independently lower alkyl or aryl; and R<4> represents lower alkyl. <CHEM>
Patent EP-0784493-A4 (EP)
Title: Impedance monitoring system
Inventor: VOSS GREGORY I
IPC: A61M5/168
Filed: 1995-09-11
Abstract: Impedance to fluid flow in a fluid delivery line is measured. Two techniques are used depending on the flow rate selected. For high flow rates, the pump is controlled to vary the flow rate and the change in pressure is divided by the change in flow to directly determine the resistance. For low flow rates, a processor controls the pump to pump flow quantities in accordance with a pseudo-random binary code. The resulting pressure signal sensed at the conduit is decoded in accordance with that code. Pressures received during code periods of no flow are subtracted from pressures received during code periods of flow. Pressure offset is also removed and a least squares estimation approach is used with a linear prediction model to determine impedance. The coefficients determined in the model are used to calculate the resistance to fluid flow of the system. A quality supervisor monitors the resistance determination process and controls the display of resistance depending on the quality determined. A resistance display continuously displays the resistance of the system.
Patent EP-0871902-A4 (EP)
Inventor: LINGREN CLINTON L
IPC: G01D18/00
Filed: 1995-12-21
Abstract: Système d'imagerie comprenant une tête de prise d'image, un processeur de signaux, un système d'acquisition de données et un ordinateur de traitement d'image. La tête de prise d'image comprend un détecteur et une ouverture servant à diriger le rayonnement vers le détecteur. Ce dernier comprend une pluralité de modules de détection serrés les uns contre les autres (206) et composés d'une pluralité d'éléments de détection (212) montés sur un support de circuit (214) comportant des canaux servant à effectuer le conditionnement et le traitement préalable des impulsions électriques qui se produisent quand un élément de détection absorbe le rayonnement. L'amplitude de l'impulsion indique l'intensité du rayonnement absorbé. Le module de détection utilise un circuit de repérage permettant de repérer automatiquement les événements corrects, c'est à dire les éléments de détection dont l'amplitude mémorisée dépasse un seuil prédéterminé.
Patent EP-0814713-A4 (EP)
Title: Top tightening bone fixation apparatus
Inventor: YOSHIMI SHUNSHIRO
IPC: A61B17/70
Filed: 1996-03-15
Abstract: The present invention includes a bone fixation apparatus comprising a bone fixation element, a linking member, and a coupling member. The coupling member has a first channel for receiving a portion of the bone fixation element and a second channel for receiving a portion of the linking member. The first and second channels are configured within the coupling member so as to allow communication of a securing force from the bone fixation element to the linking member such that the bone fixation element is rigidly secured with respect to the linking member. The bone fixation element may incorporate a conical load bearing surface which contacts the linking member through a third channel in the coupling member. Upward axial movement provided by nut tightening forces the load bearing surface of the bone fixation element against the linking member, thereby securing both within the coupling member.
Patent EP-0830139-A4 (EP)
Title: Modified myelin protein molecules
Inventor: MUELLER JOHN P
IPC: A61K31/00
Filed: 1996-04-22
Abstract: Compositions and methods are provided for the clinical assessment, diagnosis, and treatment of multiple sclerosis. The compositions of the invention are molecules related to the human proteolipid protein (PLP) and/or human myelin basic protein (MBP), and include nucleic acids and polypeptides. The nucleic acid molecules of the invention are useful in the production of modified PLP polypeptides and modified MBP polypeptides, such polypeptides being useful for assaying T cells for responsiveness to PLP and MBP epitopes. The polypeptides of the invention are also useful as therapeutic agents that act by inducing T cell responses, including anergy and apoptosis, as a means of treating multiple sclerosis.
Patent EP-0963165-A4 (EP)
IPC: A43B13/20
Filed: 1996-05-23
Abstract: A complex-contoured tensile bladder and method of making same in which a bladder comprises an envelope formed from two outer barrier layers surrounding a tensile element formed of two inner sheets. The inner sheets are attached to one another along selected first attachment portions and include die cuts at certain locations. Each of the outer barrier layers are attached to the inner sheet nearest it at selected second attachment portions which are incoincident with the selected first attachment portions. The outer layers are sealed around the periphery to form the envelope and the bladder is inflated with a gas so that the inner sheets form a tensile member which extends between the selected second portions, and the selected first portions form hinges disposed between the outer layers. When loaded the tensile member compresses at the hinges which readily allow for compression while not interfering with the cushioning properties of the gas. This construction of the bladder allows for the formation of complex-curved, contoured shapes by appropriately selecting the first attachment portions and the second attachment portions and the die cuts.
Patent EP-0844915-A4 (EP)
Inventor: CARROLL INDUSTRIES INC
IPC: C02F3/28
Filed: 1996-05-25
Abstract: Un effluent est pompé à travers un premier filtre vertical modulaire à plusieurs étages qui s'étend entre le niveau du sol et une profondeur correspondant à ou avoisinant celui de la nappe aquifère. Un accumulateur de fluide (24) situé à la base du filtre recueille l'eau provenant des étages de filtrage (20a). L'eau de l'accumulateur (24) est pompée dans le sol environnant après avoir été mise sous pression par une pompe (16) placée au niveau du sol. Le fluide s'accumulant autour du filtre est prélevé à des fins d'irrigation. Le filtre et l'accumulateur (24) peuvent être sortis du puits (22) en un seul bloc pour les révisions.
Patent EP-0842056-A4 (EP)
Title: Line marking device
Inventor: UMBRO GERALD G
IPC: B43L13/24
Filed: 1996-07-01
Abstract: A line marking device includes an elongated body which mounts a marking filament that is loaded with marking powder. When the filament is snapped against a surface a portion of the powder is deposited on that surface along a well defined line. The body also mounts a protractor and spirit levels that are used to locate or set the device in a predetermined position prior to snapping the marking filament against the surface to be marked. The marking filament extends through a shuttle chamber that contains a supply of marking powder. That shuttle is moved back and forth on the body to recharge the marking filament with marking powder. In a second embodiment of this invention the marking filament is pressed rather than snapped against the surface to be marked. In a third embodiment of this invention a writing instrument mounted on the body of the device is drawn along the length of the body to draw a line on a receiving surface adjacent the body. The writing instrument is moved by a puller filament that is windable about a spring loaded take-up reel. A holding detent of a ratchet normally acts to isolate the puller filament from operating forces that move the writing instrument.
Patent EP-0797685-A4 (EP)
Title: ANALYSIS OF GENE EXPRESSION BY DISPLAY OF 3'-END RESTRICTION FRAGMENTS OF cDNAs
Inventor: WEISSMAN SHERMAN
IPC: C12Q1/68
Filed: 1996-07-30
Abstract: The present invention is directed to an approach to study changes in gene expression by the selective PCR amplification and display of 3'-end restriction fragments of double stranded cDNAs. <IMAGE>
Patent EP-0896521-A4 (EP)
Inventor: DALLA RIVA TOMA JOAN
IPC: A61K6/00
Filed: 1997-04-28
Abstract: La présente invention concerne une composition et un procédé pour la prévention et la réduction de l'eczéma de contact. La composition contient un polysaccharide, un saccharide synergique de bas poids moléculaire, un solvant et, éventuellement, un produit additif. L'invention concerne en outre un écran protecteur dermo-compatible pour la prévention et la réduction de l'eczéma de contact qui contient un polysaccharide, un saccharide synergique de bas poids moléculaire et, éventuellement, un ou plusieurs additifs. L'écran protecteur dermo-compatible est constitué d'une composition contenant un polysaccharide, un saccharide synergique de bas poids moléculaire, un solvant et, éventuellement, un produit additif. La composition est un produit pour le soin de la peau qui s'utilise sous forme de lotion, de gel ou de crème à appliquer sur la peau des mammifères. Après application, le solvant présent dansla composition s'évapore, laissant en place un écran protecteur dermo-compatible contenant un polysaccharide, un saccharide synergique de bas poids moléculaire et, éventuellement, un produit additif.
Patent EP-0960209-A4 (EP)
Inventor: MALIGA PAL
IPC: C12N5/10
Filed: 1997-06-13
Abstract: L'invention concerne de nouvelles constructions d'ADN permettant de sélectionner des transformants plastidiaux chez des plantes supérieures. L'invention concerne également des gènes marqueurs sélectionnables fondés sur l'édition, ladite édition devant s'effectuer au niveau de la transcription pour l'expression du gène marqueur sélectionnable. Des vecteurs, y compris lesdites séquences amont éditées et liées fonctionnellement à des gènes marqueurs sélectionnables, facilitent, chez des plantes supérieures, l'isolement de transformants plastidiaux plutôt que de transformants nucléaires.
Patent EP-0984800-A4 (EP)
Inventor: CHAPMAN JOHN
IPC: A61M1/02
Filed: 1998-04-29
Abstract: La présente invention concerne un procédé permettant d'atténuer les risques de transmission de l'encéphalopathie spongiforme par des produits sanguins. Ce procédé consiste notamment à supprimer, intact, sensiblement tous les leucocytes présents, dans le produit sanguin, ou dans un intermédiaire du produit sanguin, avant d'administrer ce produit sanguin à un patient.
Patent EP-1004143-A4 (EP)
Inventor: THOMPSON MARK E
IPC: H01L31/00
Filed: 1998-07-10
Abstract: L'invention concerne des compositions multicouches comprenant plusieurs complexes métalliques en forme de pilier placés sur un substrat de support, les piliers comportant des fragments accepteurs d'électrons bivalents dotés de phosphonate ou d'arséniate à chaque extrémité. Les piliers peuvent être électrondonneurs, électroaccepteurs ou générateurs de charge de nature. Chaque couche de piliers parallèles est séparée par une couche constituée d'un lanthanide ou d'un métal de groupe (IVA), (IVB), (IIIA) ou (IIIB). Lesdites compositions peuvent également comprendre des particules constituées d'au moins un métal du groupe VIII à la valence zéro, piégées dans chaque couche du complexe. Les complexes peuvent également comporter des 'stalactites' et des 'stalagmites' de ligands arsonato ou phosphonato coiffés, intercalés avec les piliers, produisant ainsi une série d'interstices sur chaque groupe électroaccepteur. Le substrat de support peut se composer d'une matrice polymère organique. Les complexes sont utiles pour la conversion et le stockage d'énergie solaire, pour la production de photocourants et comme catalyseurs pour les réactions de réduction, comme par exemple, la production de peroxyde d'hydrogène à partir d'oxygène et d'hydrogène gazeux, la production de H2 gazeux à partir de l'eau et la réduction de cétones pour la formation d'un d'alcools.
Patent EP-1010425-A4 (EP)
Title: Remedies for irritable bowel syndrome
Inventor: ABE MICHIKAZU
IPC: A61K31/335
Filed: 1998-08-19
Abstract: Preventives and/or remedies for irritable bowel syndrome which contain as the active ingredient substances selected from the group consisting of alkylenedioxybenzene derivatives represented by general formula (I) (for example 5-[3- [(2S)-(1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1, 3-benzodioxole), pharmaceutically acceptable salts thereof, and hydrates and solvates of both, wherein m is an integer of from 2 to 5; and n is an integer of from 1 to 3.
Patent EP-1018991-A4 (EP)
Title: Contraceptive transcervical fallopian tube occlusion devices and methods
Inventor: NIKOLCHEV JULIAN N
IPC: A61F6/18
Filed: 1998-09-23
Abstract: A delivery system comprises an occlusion device (100, 200) having a proximal portion adjacent a proximal end (114, 208) and a distal portion adjacent a distal end (116, 210). The distal portion has flexibility suitable to function as a guide wire. A delivery catheter (256) is slidably disposed over the proximal portion of the occlusion device so that the distal portion remains exposed when the occlusion device and delivery catheter are advanced within a body lumen. The occlusion device is expandable from a low profile configuration within the delivery catheter to a deployed configuration when deployed from the catheter.
Patent EP-1090154-A4 (EP)
Title: Iron modified tin brass
Inventor: BRAUER DENNIS R
IPC: C22C9/00
Filed: 1999-05-12
Abstract: There is provided a tin brass alloy having a grain structure that is refined by the addition of controlled amounts of both zinc and iron. Direct chill cast alloys containing from 1 % to 4 %, by weight of tin, from 0.8 % to 4 % of iron, from an amount effective to enhance iron initiated grain refinement to 35 % of zinc and the remainder copper and inevitable impurities are readily hot worked. The zinc addition further increases the strength of the alloy and improves the bend formability in the 'good way', perpendicular to the longitudinal axis of a rolled strip. Certain of the grain refined brass alloys are useful as semisolid forming feedstock.
Patent EP-1094761-A4 (EP)
Title: A mandibular advancement device
Inventor: AMELIA BLUE
IPC: A61F5/56
Filed: 1999-07-06
Abstract: A mandibular advancement device is disclosed. The upper jaw (12) has fitted to it an upper plate (30). The upper plate (30) is firmly received, and generally comprises a body component (32) and two opposed flange components (34), are located to be lying in an area beside and close to the posterior teeth, and particularly the buccal side of the upper posterior teeth. The leading edge (36) of the flanges (34) provide engagement surfaces complementing the engagement surfaces of the trailing edges (26) of the lower flanges (24). The relative lengths of the respective trailing edges (26) and leading edges (36) ensure that mandibular advancement is maintained over a desired range of jaw openings. The angle of inclination of the engaging edges (26, 36) provides a jaw opening path generally arcuate with the protrusive border path.
Patent EP-1031555-A4 (EP)
Title: N-cyclopropyl-2-difluoromethoxy-3-halogenoanilines and intermediates for the preparation thereof
Inventor: YOSHIDA YASUO
IPC: C07C229/30
Filed: 1999-08-11
Abstract: The main tasks of the present invention are to provide, from a raw material which is industrially inexpensive and easy to procure, an N-cyclopropyl-2-difluoromethoxy-3-halogenoaniline which is an important intermediate in production of a quinolonecarboxylic acid having a cyclopropyl group at the 1-position, an isoindolinyl group at the 7-position and a difluoromethoxy group at the 8-position, useful as a synthetic antibacterial agent; and an intermediate used for production thereof. <??>The present invention provides:  a difluoromethoxybenzene derivative represented by the following formula (1): <CHEM> wherein X is a halogen atom and Y is a nitro group or an amino group; an N-(1-alkoxycyclopropyl)-2-difluoromethoxy-3-halogenoaniline derivative represented by the following formula (2): <CHEM> wherein X is a halogen atom and R<1> is a lower alkyl group; and an N-cyclopropyl-2-difluoromethoxy-3-halogeno-aniline derivative represented by the following formula (3): <CHEM> wherein X is a halogen atom and R is a hydrogen atom or a 2,2-di(alkoxycarbonyl)ethylene group represented by the following formula (4): -CH=C(CO 2R<2>)2 (wherein R<2> is a lower alkyl group).
Patent EP-1102783-A4 (EP)
Inventor: MANOHARAN MUTHIAH
IPC: C07H19/167
Filed: 1999-08-09
Abstract: On décrit des monomères nucléosidiques et des composés oligomères préparés à partir de ces derniers qui présentent une meilleure résistance aux nucléases, possèdent des groupes substituants (tels que des groupes 2'-aminooxy) qui améliorent l'affinité de liaison au brin complémentaire, et des régions de nucléotides 2'-désoxy-érythro-pentofuranosyle qui activent RNase H. Ces composés oligomères sont utiles à des fins de diagnostic et de recherche, pour moduler l'expression d'une protéine dans des organismes, et pour diagnostiquer, détecter et traiter d'autres états pathologiques susceptibles d'être traitées par les oligonucléotides.